{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:12:55Z","timestamp":1784819575862,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.amjcard.2014.02.033","type":"journal-article","created":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T20:01:29Z","timestamp":1393704089000},"page":"1765-1771","source":"Crossref","is-referenced-by-count":103,"title":["Statin Intolerance"],"prefix":"10.1016","volume":"113","clinical-trial-number":[{"clinical-trial-number":"nct01709513","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Zahid","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2014.02.033_bib1","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","author":"Stone","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2014.02.033_bib2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-137-7-200210010-00009","article-title":"Statin-associated myopathy with normal creatine kinase levels","volume":"137","author":"Phillips","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2014.02.033_bib3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cjca.2011.05.007","article-title":"Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian Working Group Consensus Conference","volume":"27","author":"Mancini","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.amjcard.2014.02.033_bib4","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/01.CIR.0000032466.44170.44","article-title":"ACC\/AHA\/NHLBI Clinical Advisory on the Use and Safety of Statins","volume":"106","author":"Pasternak","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2014.02.033_bib5","doi-asserted-by":"crossref","first-page":"89C","DOI":"10.1016\/j.amjcard.2006.02.030","article-title":"Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force","volume":"97","author":"McKenney","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2014.02.033_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ymgme.2011.07.001","article-title":"Genetic risk for malignant hyperthermia in non-anesthesia-induced myopathies","volume":"104","author":"Vladutiu","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.amjcard.2014.02.033_bib7","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1161\/CIRCULATIONAHA.106.624890","article-title":"Risks associated with statin therapy: a systematic overview of randomized clinical trials","volume":"114","author":"Kashani","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2014.02.033_bib8","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2011.07.023","article-title":"Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing","volume":"56","author":"Bjornsson","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.amjcard.2014.02.033_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0021-9150(80)90124-0","article-title":"Therapeutic effects of ML-236B in primary hypercholesterolemia","volume":"35","author":"Yamamoto","year":"1980","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2014.02.033_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1056\/NEJM198801073180111","article-title":"Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation","volume":"318","author":"East","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2014.02.033_bib11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJM198801073180110","article-title":"Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin","volume":"318","author":"Norman","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2014.02.033_bib12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJM200202143460721","article-title":"Cerivastatin and reports of fatal rhabdomyolysis","volume":"346","author":"Staffa","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2014.02.033_bib13","doi-asserted-by":"crossref","first-page":"34P","DOI":"10.1016\/j.amjcard.2006.09.018","article-title":"Molecular basis of differences among statins and a comparison with antioxidant vitamins","volume":"98","author":"Mason","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2014.02.033_bib14","article-title":"The effect of statins on skeletal muscle function","author":"Parker","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2014.02.033_bib15","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1001\/archinte.165.22.2671","article-title":"Outcomes in 45 patients with statin-associated myopathy","volume":"165","author":"Hansen","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2014.02.033_bib16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/mus.20567","article-title":"Genetic risk factors associated with lipid-lowering drug-induced myopathies","volume":"34","author":"Vladutiu","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.amjcard.2014.02.033_bib17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","article-title":"Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients\u2014the PRIMO study","volume":"19","author":"Bruckert","year":"2005","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.amjcard.2014.02.033_bib18","unstructured":"FDA Public Health Advisory for Crestor (rosuvastatin). http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/PublicHealthAdvisories\/ucm051756.htm, Access Date: February 18, 2014."},{"key":"10.1016\/j.amjcard.2014.02.033_bib19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jacl.2012.03.003","article-title":"Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users","volume":"6","author":"Cohen","year":"2012","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.amjcard.2014.02.033_bib20","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1161\/CIR.0b013e31823ac046","article-title":"Heart disease and stroke statistics\u20142012 update: a report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2014.02.033_bib21","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00002018-200730080-00003","article-title":"Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance","volume":"30","author":"Golomb","year":"2007","journal-title":"Drug Saf"},{"key":"10.1016\/j.amjcard.2014.02.033_bib22","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.amjcard.2011.08.045","article-title":"Effect of statins on creatine kinase levels before and after a marathon run","volume":"109","author":"Parker","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2014.02.033_bib23","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1503\/cmaj.081785","article-title":"Association between statin-associated myopathy and skeletal muscle damage","volume":"181","author":"Mohaupt","year":"2009","journal-title":"CMAJ"},{"key":"10.1016\/j.amjcard.2014.02.033_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2013.02.074","article-title":"Simvastatin impairs exercise training adaptations","author":"Mikus","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2014.02.033_bib25","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2007.02.049","article-title":"The role of coenzyme Q10 in statin-associated myopathy: a systematic review","volume":"49","author":"Marcoff","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2014.02.033_bib26","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.amjcard.2006.12.063","article-title":"Effect of coenzyme Q10 on myopathic symptoms in patients treated with statins","volume":"99","author":"Caso","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2014.02.033_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.atherosclerosis.2010.11.039","article-title":"The relationship of vitamin D deficiency to statin myopathy","volume":"215","author":"Gupta","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2014.02.033_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/pr.110.002857","article-title":"Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake","volume":"63","author":"Niemi","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.amjcard.2014.02.033_bib29","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy\u2014a genomewide study","volume":"359","author":"Link","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2014.02.033_bib30","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(86)80293-5","article-title":"Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin","volume":"8","author":"Canner","year":"1986","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2014.02.033_bib31","doi-asserted-by":"crossref","first-page":"30C","DOI":"10.1016\/0002-9149(84)90854-3","article-title":"Lipid Research Clinics Coronary Primary Prevention Trial: results and implications","volume":"54","author":"Rifkind","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2014.02.033_bib32","doi-asserted-by":"crossref","first-page":"562","DOI":"10.7326\/0003-4819-158-7-201304020-00010","article-title":"Statin discontinuation and intolerance: the challenge of lifelong therapy","volume":"158","author":"Grundy","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2014.02.033_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11883-010-0148-x","article-title":"Statin rebound or withdrawal syndrome: does it exist?","volume":"13","author":"Pineda","year":"2011","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.amjcard.2014.02.033_bib34","doi-asserted-by":"crossref","first-page":"526","DOI":"10.7326\/0003-4819-158-7-201304020-00004","article-title":"Discontinuation of statins in routine care settings: a cohort study","volume":"158","author":"Zhang","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2014.02.033_bib35","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.amjcard.2007.09.099","article-title":"Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins","volume":"101","author":"Stein","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2014.02.033_bib36","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.clinthera.2006.06.004","article-title":"Rosuvastatin 5 and 10 mg\/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies","volume":"28","author":"Glueck","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.amjcard.2014.02.033_bib37","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0002-8703(02)00140-0","article-title":"Is alternate daily dose of atorvastatin effective in treating patients with hyperlipidemia? The Alternate Day Versus Daily Dosing of Atorvastatin Study (ADDAS)","volume":"144","author":"Matalka","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2014.02.033_bib38","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jacl.2011.03.454","article-title":"Efficacy and tolerability of once-weekly rosuvastatin in patients with previous statin intolerance","volume":"5","author":"Kennedy","year":"2011","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.amjcard.2014.02.033_bib39","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jacl.2011.11.002","article-title":"The high-dose rosuvastatin once weekly study (the HD-ROWS)","volume":"6","author":"Backes","year":"2012","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.amjcard.2014.02.033_bib40","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jacl.2008.08.430","article-title":"Ezetimibe-related myopathy: a systematic review","volume":"2","author":"Slim","year":"2008","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.amjcard.2014.02.033_bib41","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.amjcard.2008.06.050","article-title":"Effectiveness of thrice weekly ezetimibe","volume":"102","author":"Venero","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2014.02.033_bib42","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM199908053410604","article-title":"Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group","volume":"341","author":"Rubins","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2014.02.033_bib43","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.atherosclerosis.2008.02.009","article-title":"Recommendations for the use of LDL apheresis","volume":"198","author":"Thompson","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2014.02.033_bib44","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.amjcard.2009.08.672","article-title":"Tolerability of red yeast rice (2,400\u00a0mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance","volume":"105","author":"Halbert","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2014.02.033_bib45","doi-asserted-by":"crossref","first-page":"830","DOI":"10.7326\/0003-4819-150-12-200906160-00006","article-title":"Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial","volume":"150","author":"Becker","year":"2009","journal-title":"Ann Intern Med"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914914007255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914914007255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T04:21:32Z","timestamp":1538799692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914914007255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0002914914007255"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2014.02.033","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}